In trading on Thursday, shares of Alnylam Pharmaceuticals Inc (ALNY) touched a new 52-week high of $115.43/share. That's a 145.44% rise, or $68.4 per share from the 52-week low of $47.03 set back on 04/28/2014. That means at today's intraday high, any investor who purchased ALNY stock any time over the past 52 weeks has an unrealized gain, including company insiders.Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely. As summarized by the table below, ALNY has seen 2 different instances of insiders buying over the trailing six month period.
|01/26/2015||Steven M. Paul||Director||1,000||$95.00||$95,000.00|
|01/26/2015||John Maraganore||Chief Executive Officer||10,000||$95.00||$950,000.00|
In afternoon trading on Thursday, ALNY shares are changing hands at $110.87/share, slightly below the new 52-week high.